FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Vaccine | flu vaccine

FDA selects flu strains for next round of vaccines

Tools
  • Email
  • Print
  • Comment
  • Contact Author
  • Reprint

The FDA has come up with a lineup of three all-new flu strains for this year's vaccine recipe. Typically, only one or two strains are changed, but health officials felt that following last season's ineffective vaccine jab a new approach was called for.

It's not easy getting the strains right. Most vaccines are consistently effective against their targets. But the steadily changing nature of influenza makes it a tough target to hit. Inevitably, there's always a guessing game about which strains will be circulating during an upcoming flu season.

This season's list of manufacturers and approved vaccines (by way of the Washington Post): CSL Limited, Afluria; GlaxoSmithKline Biologicals, Fluarix; ID Biomedical, FluLaval; MedImmune Vaccines, FluMist; Novartis Vaccines and Diagnostics, Fluvirin; and Sanofi Pasteur, Fluzone.

- read the story from the Washington Post

Related Articles:
Flu jab missing the mark in seasonal campaign
Vaccines ineffective in seasonal flu campaign
Breakthrough reported in flu vaccine research

More stories about Vaccine   flu vaccine  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 14 + 18?
To combat spam, please solve the math question above.